A business in context

UPC research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 6-K · Current report

    Report date 2026-10-06 · 0001213900-26-107197

  2. 6-K/A · Current report

    Report date 2026-09-03 · 0001213900-26-097225

  3. 6-K · Current report

    Report date 2026-09-01 · 0001213900-26-096306

  4. 6-K · Current report

    Report date 2026-07-31 · 0001213900-26-083956

  5. 6-K · Current report

    Report date 2026-03-31 · 0001213900-26-082789

  6. 6-K · Current report

    Report date 2026-06-26 · 0001213900-26-072603

  7. 4 · Ownership change

    Report date 2026-05-07 · 0001213900-26-060060

  8. 6-K · Current report

    Report date 2026-05-14 · 0001213900-26-056617

  9. 6-K · Current report

    Report date 2026-04-16 · 0001213900-26-044641

  10. 6-K · Current report

    Report date 2026-02-11 · 0001213900-26-014886

  11. 20-F · Annual report

    Report date 2025-09-30 · 0001213900-26-009000

  12. 6-K · Current report

    Report date 2025-09-03 · 0001213900-25-084040

  13. 6-K · Current report

    Report date 2025-08-26 · 0001213900-25-080750

  14. 6-K · Current report

    Report date 2025-07-29 · 0001213900-25-068704

  15. 6-K · Current report

    Report date 2025-07-03 · 0001213900-25-061480

  16. 20-F · Annual report

    Report date 2024-09-30 · 0001213900-25-036798

  17. 6-K · Current report

    Report date 2025-03-20 · 0001213900-25-025300

  18. 6-K · Current report

    Report date 2025-03-11 · 0001213900-25-022737

  19. 6-K · Current report

    Report date 2025-03-03 · 0001213900-25-019406

  20. 6-K · Current report

    Report date 2025-02-25 · 0001213900-25-017079

  21. 6-K · Current report

    Report date 2025-02-20 · 0001213900-25-015667

  22. 6-K · Current report

    Report date 2025-02-18 · 0001213900-25-014864

  23. 6-K · Current report

    Report date 2025-02-11 · 0001213900-25-012207

  24. 6-K · Current report

    Report date 2025-02-03 · 0001213900-25-009434

  25. 6-K · Current report

    Report date 2025-01-30 · 0001213900-25-008083

  26. 6-K · Current report

    Report date 2024-12-12 · 0001213900-24-108402

  27. 6-K · Current report

    Report date 2024-11-13 · 0001213900-24-097143

  28. 6-K · Current report

    Report date 2024-11-01 · 0001213900-24-093481

  29. 6-K · Current report

    Report date 2024-10-10 · 0001213900-24-086890

  30. 6-K · Current report

    Report date 2024-09-27 · 0001213900-24-082702

  31. 6-K · Current report

    Report date 2024-03-31 · 0001213900-24-080675

  32. 6-K · Current report

    Report date 2024-09-03 · 0001213900-24-075078

  33. 6-K · Current report

    Report date 2024-07-18 · 0001213900-24-062550

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001809616Universe Pharmaceuticals INC

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2025-09-30$17.86B$18.80B
    2024-09-30$23.02B$24.90B
    2023-09-30$32.31B$36.01B
    2022-09-30$40.14M$47.01M
    2021-09-30$47.98M$60.64M
    2020-09-30$30.70M$40.10M
    2019-09-30$33.23M$44.01M

    Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

    Explore the CPI history ↗